US P&C turned a corner in record Q1; watch for growth spurts: Swiss Re
Swiss Re is changing its tune on the US P&C industry following what it called the industry's best first quarter set of earnings in 15 years, but stopped short of increasing its outlook save to admit “risks to the upside.”
“After consistently weak sector results for near two years, the dog days are over,” analysts at the Swiss Re Institute wrote in their quarterly review of the US P&C market.
Q1 2024 brought a further improvement of the combined ratio to 94.4%, rendering the second quarter of technical profits after an extended period of dog days and the best Q1 underwriting results in 15 years, analysts noted.
But forecasts are unmoved: Swiss Re still expects a combined ratio of 98.5% for both 2024 and 2025, flat to the prior stirring of the tea leaves. Premium growth forecasts of 8% in 2024 and 5% in 2025 are also both flat to the prior forecast.
“We are still in the early stages of what is forecast to be an active Atlantic hurricane season,” analysts said of their hold on margin outlook following a first quarter boosted by low cat activity. The early view to Q2 already suggests an above-average hit, they added.
Growth is where Swiss Re sees the upside risks to its own forecasts following a spike to 10% growth in Q1 2024.
Personal lines could be the driver, especially as “personal auto rushes back to competition.” Ad spend for personal auto more than doubled from Q4 2023 to Q1 2024 and was still rising heading into what should be a slow season, analysts wrote.
Commercial lines, in turn, are slowing, with property lines seeing a notable deceleration in Q1 2024, analysts noted.
Towards the bottom line, Swiss Re Institute continues to forecast a return on equity at 9.5% in 2024 and 10% in 2025, supported also by rising investment yields.
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk